Generalized anxiety disorder comorbid with depression. Generalized anxiety disorder
Conditions
Interventions
Intervention 1: Intervention group: group 1: UP group. Unified protocol for transdiagnostic of emotional disorders consists of a maximum of 12, 60-minute individual treatment sessions. The UP targets
increasing awareness and confronting with physical sensations, and facing with emotions in situations. The treatment is preceded by enhancing motivation and readiness of individuals for change and tre
Sponsors
Ferdowsi University of Mashhad
Eligibility
Sex/Gender
All
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Diagnostic DSM-V criteria for GAD as the primary diagnosis and depression disorder as a comorbid disorder If the drug was taken, it was possible to maintain the type and amount of the drug during the study period Be a minimum 18 years and a maximum 40 years old Patient's consent to participate in research and to sign written consent Speak Persian fluently Ability to participate in all assessment and treatment sessions
Exclusion criteria
Exclusion criteria: Need for immediate medical treatment or the need for concurrent therapeutic interventions in such a way as to interfere with the treatment program Not having previous experience in at least eight sessions of treatment based on the cognitive-behavioural therapy in the last 5 years Having psychiatric disorders and substance abuse Current diagnosis of any mental disorder in the axes I and II, with the exception of GAD and depression Patient's opposition to collaboration at any time of research Having serious thoughts about Suicide History of experiencing other psychological treatments
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Score of generalized anxiety from GAD-Q-IV questionnaire. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: GAD-Q-IV questionnaire.;Score of depression from Beck depression questionnaire. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Beck depression questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Score of worry from PSWQ. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: PSWQ questionnaire.;Score of intolerance of uncertainty from IUS. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: IUS questionnaire.;Score of cognitive fusion from CFQ. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: CFQ questionnaire.;Score of cognitive avoidance from CAQ. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: CAQ questionnaire.;Score of difficulties in emotion regulation from DERS. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: DERS questionnare.;Score of cognitive emotion regulation from CERQ. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: CERQ questionnaire.;Score of emotion regulation from ERQ. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: ERQ questionnaire.;Score of anxiety sensitivity from ASI. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: ASI questionnaire.;Score of cognitive flexibility from Wisconsin test. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Wisconsin card sorting test.;Score of inhibition from go/no go test. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Go/no go software.;Score of working memory from n-back test. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: N- back software. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarzad Nasiri
Ferdowsi University of Mashhad
Outcome results
None listed